![Philip Haworth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Haworth
No open positions remaining
Profile
Philip Haworth formerly worked at TVAX Biomedical, Inc., as Chief Executive Officer, Intradigm Corp., as Chief Executive Officer, Silence Therapeutics Plc, as Chief Executive Officer & Director from 2010 to 2011, COR Therapeutics, Inc., as Principal, Genencor International, Inc., as Principal, Codexis, Inc., as Vice President-Business Development, and Affymax, Inc., as Principal.
Dr. Haworth received his graduate degree from Stanford University, doctorate degree from The University of Manchester, and undergraduate degree from The University of Southampton.
Former positions of Philip Haworth
| Companies | Position | End |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Chief Executive Officer | 2011-07-31 |
| TVAX BIOM | Chief Executive Officer | - |
| CODEXIS, INC. | Corporate Officer/Principal | - |
| AFFYMAX, INC. | Corporate Officer/Principal | - |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Corporate Officer/Principal | - |
Training of Philip Haworth
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Health Technology |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
TVAX Biomedical, Inc.
 TVAX Biomedical, Inc. BiotechnologyHealth Technology Manufactures and sells healthcare products | Health Technology |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Philip Haworth
